Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tauns Laboratories, Inc. ( (JP:197A) ) has issued an update.
TAUNS Laboratories, Inc. has secured a patent in Japan for a novel immunoassay-based method and reagent that enhances sensitivity and reduces cost in detecting target substances like antigens. This development aims to facilitate advanced testing capabilities in point-of-care settings, potentially improving medical care efficiency, although it currently has no material impact on the company’s financial results.
More about Tauns Laboratories, Inc.
TAUNS Laboratories, Inc. operates within the medical industry, focusing on innovative testing technologies. The company specializes in developing advanced diagnostic methods and reagents, with a market emphasis on enhancing medical testing efficiency and accessibility.
YTD Price Performance: 0.16%
Average Trading Volume: 960,876
Technical Sentiment Consensus Rating: Strong Sell
See more data about 197A stock on TipRanks’ Stock Analysis page.
